ZSQR on Nasdaq

Z Squared Inc.

Therapeutics, Inc., which we now continue to operate as our wholly owned subsidiary.4 From its latest annual report

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with Magic Empire Global Ltd, Brera Holdings PLC or Grande Group Ltd/HK, or pick any stock.

  • TickerZSQR on Nasdaq2
  • IndustryFinance Services2
  • HeadquartersFort Lauderdale, United States2
  • Incorporated inDE3
  • Business address550 South Andrews Ave., Ste #700, Fort Lauderdale, Fl 333013
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formCorporation2
  • LEI5299004UXP8XTVR4KR352
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressc/o CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 70938312

See how the biggest companies compare on our leaderboards

Therapeutics, Inc., which we now continue to operate as our wholly owned subsidiary.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

86.7%Gross margin5
-956.9%Operating margin5
-874.3%Net margin5
-87.9%Return on equity5
0.01×Debt to equity5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Advertising Campaigns brought in 92% of the revenue Z Squared Inc. broke down this way in fiscal 2025.

  1. Advertising Campaigns$1.3M592%
  2. Webinar Services$112.5K58%
Products and services by year
Products and services20242025
Advertising Campaigns$1.3M
Webinar Services$112.5K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue12¢$180.6K
  • Research and development88¢$1.3M

Out of $1.4M in revenue.5 The company lost money this year.

Financial statements

Revenue6785$1.4M in 2025+1717% since 2021
0$500.0K$1.0M$1.5M2021: $75.0K$75.0K20212022: $0$020222023: $0$020232024: $0$020242025: $1.4M$1.4M2025
Gross profit6785$1.2M in 2025+1477% since 2021
0$500.0K$1.0M$1.5M2021: $75.0K$75.0K20212022: $0$020222023: $0$020232024: $0$020242025: $1.2M$1.2M2025
Operating income9106785-$13.0M in 2025+583763% since 2019
-$40.0M-$30.0M-$20.0M-$10.0M02019: -$2.2K-$2.2K20192020: -$68.4K-$68.4K2020+2963%2021: -$14.0M-$14.0M2021+20426%2022: -$34.2M-$34.2M2022+143%2023: -$21.5M-$21.5M2023−37%2024: -$10.1M-$10.1M2024−53%2025: -$13.0M-$13.0M2025+30%
Net income9106785-$11.9M in 2025+533338% since 2019
-$40.0M-$30.0M-$20.0M-$10.0M02019: -$2.2K-$2.2K20192020: -$17.3M-$17.3M2020+773390%2021: -$13.4M-$13.4M2021−22%2022: -$37.6M-$37.6M2022+179%2023: -$21.3M-$21.3M2023−43%2024: -$10.7M-$10.7M2024−50%2025: -$11.9M-$11.9M2025+12%

Every line of the income statement as filed: the last 2 fiscal years, latest first.5

Period ending2025-12-312024-12-31
Total sales$1.4M$0
Cost of goods$180.6K$0
Gross profit$1.2M$0
Research and development expense$1.3M$2.3M
Salary expense$1.7M$1.7M
Amortization expense$1.0M$1.0M
Professional services expense$7.8M$3.0M
Stock based compensation expense$1.2M$1.1M
General and administrative expenses$1.1M$945.6K
Selling and marketing expense$105.0K$0
Total cost of operations$14.2M$10.1M
LOSS FROM OPERATIONS-$13.0M-$10.1M
Interest expense-$96.7K-$246.1K
Interest income$116.5K$234.7K
Amortization of debt discount-$545.6K-$216.2K
Gain on forfeiture of customer deposit$115.0K$0
Other income (expense), net$7.0K-$16.4K
Unrealized gain on marketable securities$76.6K$0
Unrealized loss on investments-$163.5K$0
Loss on write down of assets$0-$37.3K
Gain (loss) on extinguishment of debt$159.0K-$200.0K
Change in fair value of derivative liabilities$1.1M-$341.7K
TOTAL OTHER INCOME (EXPENSE), net$766.3K-$822.9K
LOSS BEFORE INCOME TAXES-$12.3M-$10.9M
PROVISION FOR INCOME TAXES (BENEFIT)$0$0
NET LOSS-$12.3M-$10.9M
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS-$360.2K-$197.0K
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS-$11.9M-$10.7M
Loss per share, basic-$2.81-$5.56
Loss per share, fully diluted-$2.81-$5.56
Weighted average number of common shares outstanding, basic4.2M shares1.9M shares
Weighted average number of common shares outstanding, diluted4.2M shares1.9M shares

Compare Z Squared Inc. with another company

Leadership

Who has led Z Squared Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Robert Striar2020
  2. David Mehalick2022–2026
  3. David Elias Halabu2026–now
  4. Michelle Ellen Burke2026–now

President

  1. David Mehalick2022–now

Chief financial officer

  1. Chris Calise2020
  2. Christine Elise Sheehy2022–2023
  3. Brian Cogley2024–now
2025
Board members and other officers (22)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerColleen Delaney named Jun 27, 202436
  • DirectorChristopher Cochran named Aug 7, 202537
  • DirectorChristopher Maria Cochran named Jun 27, 202436

Former names

  • Coeptis Therapeutics Holdings, Inc.Jun 22, 2022 to Apr 28, 20263
  • Bull Horn Holdings Corp.Feb 21, 2019 to Oct 28, 20223

Timeline

  1. Apr 29, 2026New chief executive David Elias Halabu becomes CEO13
  2. Apr 29, 2026New chief executive Michelle Ellen Burke becomes CEO14
  3. Nov 7, 2022New chief executive David Mehalick becomes CEO15
  4. Oct 27, 2022Founded Z Squared Inc. is founded2
  5. Oct 30, 2020New chief executive Robert Striar becomes CEO16

Filings

307 filings to the SEC since October 2021: 9 annual reports, 20 quarterly reports, 60 major events, 75 insider forms, 24 large holders, 3 private raises, 116 other. The latest 20:

  1. Oct 5, 20264 EDGAR
  2. Oct 2, 20264 EDGAR
  3. Oct 2, 20264 EDGAR
  4. Oct 2, 20264 EDGAR
  5. Oct 2, 20264 EDGAR
  6. Oct 2, 20264 EDGAR
  7. Oct 2, 20264 EDGAR
  8. Oct 2, 20264/A EDGAR
  9. Sep 14, 20268-K EDGAR
  10. Sep 10, 20268-K EDGAR
  11. Aug 26, 20268-K EDGAR
  12. Aug 25, 20264 EDGAR
  13. Aug 21, 2026S-8 EDGAR
  14. Aug 20, 20264 EDGAR
  15. Aug 13, 202610-Q EDGAR
  16. Aug 4, 20268-K EDGAR
  17. Jul 31, 2026SCHEDULE 13G/A EDGAR
  18. Jul 27, 2026POSASR EDGAR
  19. Jul 22, 20268-K EDGAR
  20. Jul 10, 20268-K EDGAR

The 307 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

12 open-market trades by officers, directors and large owners since October 2021: 11 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 18, 2026Schadel Christopher RyanChief Marketing OfficerBuy1,000$3.92$3.9KForm 4
Jan 12, 2024DeSilva TaraDirectorBuy2,266$0.58$1.3KForm 4
Jan 10, 2024Cogley BrianChief Financial OfficerBuy5,000$0.67$3.4KForm 4
Jan 8, 2024Mehalick DavidCEO and PresidentBuy20,004$0.66$13.3KForm 4
Jan 5, 2024Yerace Daniel AlexanderVP OperationsBuy10,850$0.69$7.5KForm 4
Jan 5, 2024Salkind GeneDirectorBuy11,600$0.69$8.0KForm 4
Jan 5, 2024Mehalick DavidCEO and PresidentBuy5,050$0.69$3.5KForm 4
Jan 5, 2024Cochran Christopher P.DirectorBuy7,000$0.77$5.4KForm 4
Aug 29, 2023Salkind GeneDirectorBuy4,006$1.01$4.0KForm 4
Aug 25, 2023Salkind GeneDirectorBuy28,638$0.91$26.1KForm 4
Aug 23, 2023Calise ChrisDirectorBuy11,582$0.94$10.9KForm 4
May 4, 2022Harraden Circle Investors GP, LP10% ownerSale85,305$10.11$862.4KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Jul 24, 2025Raised $4 million in a private offering of equity Form D: $5 million offered in all Form D
  2. Jun 14, 2024Raised $4.3 million in a private offering of equity Form D: $10 million offered in all Form D
  3. Oct 26, 2023Raised $2 million in a private offering of equity Form D: 1 investor so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 44. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.2,520,856$26.7M0.0%New
Vanguard Capital Management LLC1,670,495$17.7M0.0%New
Geode Capital Management, LLC713,196$7.5M0.0%New
Northern Trust Corp346,687$3.7M0.0%New
Vanguard Portfolio Management LLC303,288$3.2M0.0%New
Vanguard Fiduciary Trust Co128,391$1.4M0.0%New
Nuveen, LLC104,189$1.1M0.0%New
Charles Schwab Investment Management Inc103,522$1.1M0.0%New
Bank of New York Mellon Corp91,603$969.2K0.0%New
United Capital Financial Advisors, LLC86,062$910.5K0.0%New
UBS Group AG70,148$742.2K0.0%New
Rhumbline Advisers49,649$525.3K0.0%New
Deutsche Bank Ag\43,667$462.0K0.0%New
Wells Fargo & Company/mn40,056$423.8K0.0%New
Wellington Management Group Llp33,100$350.2K0.0%New
MetLife Investment Management, LLC26,305$278.3K0.0%New
Bank Of America Corp /de/25,189$266.5K0.0%New
Invesco Ltd.23,857$252.4K0.0%New
Jpmorgan Chase & Co19,475$227.3K0.0%New
Citigroup Inc20,602$218.0K0.0%New
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.20,134$213.0K0.0%New
Morgan Stanley16,695$176.6K0.0%New
Sagespring Wealth Partners, LLC15,708$166.2K0.0%New
New York State Common Retirement Fund15,400$162.9K0.0%New
Alliancebernstein L.P.13,160$139.2K0.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53